Salarius Pharmaceuticals Inc (FRA:FP10)
€ 3.008 0 (0%) Market Cap: 1.26 Mil Enterprise Value: -2.68 Mil PE Ratio: 0 PB Ratio: 0.34 GF Score: 29/100

Salarius Pharmaceuticals Inc at SNN Network Transcript

Nov 20, 2019 / NTS GMT
Release Date Price: €584 (+0.69%)
Robert Kraft
SNN Incorporated - Moderator

This is Robert Kraft, and I'm coming to you live on SNNLive. And we're at the MicroCap Rodeo 2019 in Austin, Texas. With me right now is David Arthur from Salarius Pharmaceuticals. It's a publicly traded company. The symbol is SLRX.

David, welcome to SNN Live.

David Arthur
Salarius Pharmaceuticals, Inc. - CEO

Robert, thank you for having us. It's great to be here.

Questions & Answers

Robert Kraft
SNN Incorporated - Moderator

It's great to have you. So for our audience, let's start off with an overview of the company and then we'll go from there.

David Arthur
Salarius Pharmaceuticals, Inc. - CEO

Absolutely. Salarius is an oncology-based biotechnology company, developing drugs for patients who need them the most. We're located here in Texas, down in Houston at the JLABS innovation Center.

Robert Kraft
SNN Incorporated - Moderator

So let's get a history of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot